PMID- 37077169
OWN - NLM
STAT- MEDLINE
DCOM- 20230828
LR  - 20230901
IS  - 2165-0969 (Electronic)
IS  - 2165-0799 (Print)
IS  - 2165-0799 (Linking)
VI  - 71
IP  - 9
DP  - 2023 Sep
TI  - Medicinal Cannabis and Implications for Workplace Health and Safety: Scoping 
      Review of Systematic Reviews.
PG  - 400-410
LID - 10.1177/21650799231157086 [doi]
AB  - PURPOSE: Although medicinal cannabis is prescribed for conditions such as pain, 
      epilepsy, nausea and vomiting during cancer treatment, evidence about associated 
      adverse side effects is still evolving. Because adverse events (AEs) might impact 
      the performance of workers, it is important to consider their implications on 
      workplace health and safety (WHS). This study aimed to map the types and 
      prevalence of the AEs associated with medical cannabis and articulate how those 
      events could impact WHS. METHODS: A scoping review of systematic reviews and/or 
      meta-analyses published between 2015 and March 2021 was performed to identify the 
      AEs of medicinal cannabis in adults. Publications in English and full text 
      available online were collected from Embase, MEDLINE, PsychINFO, PubMed, Scopus, 
      and Web of Science. RESULTS: Of 1,326 papers identified from the initial search, 
      31 met the inclusion criteria and were analyzed. The studies reported various AEs 
      with the most predominant being sedation, nausea/vomiting, dizziness, and 
      euphoria. Acute and chronic pain was the most prevalent disorder under review. 
      CONCLUSIONS: Adverse events associated with the use of medicinal cannabis could 
      increase workplace risks, including decreased alertness and reaction times, 
      increased absenteeism, reduced ability to safely drive or operate machinery and 
      an increased probability of falling. Focused research into the risk to workers 
      and workplaces from the use of medical cannabis and related human performance 
      impairment is urgently warranted.
FAU - O'Neill, Veronica
AU  - O'Neill V
AUID- ORCID: 0000-0002-3547-0040
AD  - Queensland University of Technology.
FAU - Karanikas, Nektarios
AU  - Karanikas N
AD  - Queensland University of Technology.
FAU - Sav, Adem
AU  - Sav A
AD  - Queensland University of Technology.
FAU - Murphy, Patricia
AU  - Murphy P
AD  - Independent researcher.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230419
PL  - United States
TA  - Workplace Health Saf
JT  - Workplace health & safety
JID - 101575677
RN  - 0 (Medical Marijuana)
MH  - Adult
MH  - Humans
MH  - *Medical Marijuana/adverse effects
MH  - Systematic Reviews as Topic
MH  - Vomiting/chemically induced/drug therapy
MH  - Nausea/chemically induced/drug therapy
MH  - Working Conditions
PMC - PMC10467002
OTO - NOTNLM
OT  - adverse events
OT  - medical cannabis
OT  - occupational health and safety
OT  - safety management
COIS- The author(s) declared no potential conflicts of interest with respect to the 
      research, authorship, and/or publication of this article.
EDAT- 2023/04/20 06:42
MHDA- 2023/08/28 06:42
PMCR- 2023/08/30
CRDT- 2023/04/20 02:13
PHST- 2023/08/28 06:42 [medline]
PHST- 2023/04/20 06:42 [pubmed]
PHST- 2023/04/20 02:13 [entrez]
PHST- 2023/08/30 00:00 [pmc-release]
AID - 10.1177_21650799231157086 [pii]
AID - 10.1177/21650799231157086 [doi]
PST - ppublish
SO  - Workplace Health Saf. 2023 Sep;71(9):400-410. doi: 10.1177/21650799231157086. 
      Epub 2023 Apr 19.